Results overview: Found 2 records in 0.02 seconds.
Articles, 2 records found
Articles 2 records found  
1.
8 p, 1.6 MB Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer : a subgroup analysis from the phase 3 TAGS study / Mansoor, Wasat (The Christie NHS Foundation Trust) ; Arkenau, Hendrik-Tobias (University College London) ; Alsina, Maria (Vall d'Hebron Institut d'Oncologia) ; Shitara, Kohei (National Cancer Center Hospital East) ; Thuss-Patience, Peter (Charité - Universitätsmedizin Berlin) ; Cuffe, Sinead (St. James's Hospital ( Dublín, Irlanda)) ; Dvorkin, Mikhail (Omsk Regional Clinical Centre of Oncology) ; Park, David (St, Joseph Heritage Healthcare) ; Ando, Takayuki (University of Toyama) ; Van Den Eynde, Marc (UCL Cliniques Universitaires Saint-Luc) ; Beretta, Giordano D. (Humanitas Gavazzeni) ; Zaniboni, Alberto (Fondazione Poliambulanza-Istituto Ospedaliero) ; Doi, Toshihiko (National Cancer Center Hospital East) ; Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ; Ilson, David H. (Memorial Sloan Kettering Cancer Center) ; Makris, Lukas (Stathmi, Inc, New Hope, PA USA) ; Benhadji, Karim A. (Taiho Oncology) ; Van Cutsem, Eric (University Hospitals Gasthuisberg (Leuven, Bélgica)) ; Universitat Autònoma de Barcelona
Patients with advanced gastroesophageal junction cancer (GEJC) have poor survival outcomes, and GEJC-specific data from trials evaluating agents in gastric cancers (GCs) as a whole are lacking. Trifluridine/tipiracil (FTD/TPI) was approved for previously treated metastatic GC or GEJC (mGC/mGEJC) based on results of the phase 3 TAGS trial. [...]
2021 - 10.1007/s10120-021-01156-x
Gastric Cancer, Vol. 24 (march 2021) , p. 970-977  
2.
7 p, 770.6 KB Proxies of quality of life in metastatic colorectal cancer : analyses in the RECOURSE trial / Van Cutsem, Eric (University Hospitals Leuven (Bèlgica)) ; Falcone, Alfredo (Azienda Ospedaliero-Universitaria Pisana) ; García Carbonero, Rocio (Hospital Universitario 12 de Octubre (Madrid)) ; Komatsu, Yoshito (Hokkaido University Hospital) ; Pastorino, Alessandro (IRCCS AOU San Martino IST) ; Peeters, Marc (University Hospital Antwerp (Bèlgica)) ; Shimada, Yasuhiro (National Cancer Center Hospital) ; Yamazaki, Kentaro (Shizuoka Cancer Center) ; Yoshino, Takayuki (National Cancer Center Hospital East) ; Zaniboni, Alberto (Fondazione Poliambulanza) ; Amellal, Nadia (Institut de Recherches Servier) ; Kanehisa, Akira (Institut de Recherches Servier) ; Winkler, Robert (Taiho Oncology) ; Makris, Lukas (Taiho Oncology) ; Mayer, Robert J. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Ohtsu, Atsushi (National Cancer Center Hospital East) ; Tabernero, Josep (Universitat Autònoma de Barcelona. Departament de Medicina)
In the pivotal phase III, randomised, double-blind, placebo-controlled RECOURSE study, treatment with trifluridine/tipiracil was well tolerated and associated with prolonged progression-free and overall survival in patients with metastatic colorectal cancer (mCRC). [...]
2017 - 10.1136/esmoopen-2017-000261
ESMO open, Vol. 2 (november 2017)  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.